Search results
AstraZeneca withdraws Covid-19 vaccine, citing low demand | CNN Business
CNN.com· 6 days agoThe vaccine — called Vaxzevria and developed in partnership with the University of Oxford — has been...
AstraZeneca Pulls Out Its COVID-19 Vaccine From Global Markets After Court Docs Shows Side Effects -...
EconoTimes· 6 days agoAstraZeneca plc, a British-Swedish pharmaceutical and biotechnology company, is reportedly...
AstraZeneca pulls its COVID-19 vaccine from the European market
WSLS Newschannel 10 Roanoke· 5 days agoThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine...
AstraZeneca withdraws COVID-19 vaccine citing low demand
KCCI 8 Des Moines· 5 days agoAstraZeneca is withdrawing its highly successful coronavirus vaccine, citing the availability of a...
Will your last COVID vaccine work against new ‘FLiRT’ variants?
WJZY via Yahoo News· 1 day ago(NEXSTAR) — There are two new COVID-19 variants circulating, posing a threat to a summer surge. The...
The Silence Around Covid Vaccine Injuries
The Intercept· 8 hours agoThis week on Deconstructed, Wightman shares his story with Ryan Grim. Days after receiving an AstraZeneca Covid-19 vaccine in 2021, Wightman ...
Feldman: 'You may be done with COVID, but ...'
Gannett via AOL· 13 hours agoA new booster formulation recommended for most people is anticipated for the fall. Vaccination greatly reduces the risk of severe disease and long COVID. The politicalization ...
Novavax Starts A New Chapter, Turning The Page On Financial Uncertainty
RTT News· 12 hours agos (NVAX) future as a going concern seemed uncertain, a remarkable turnaround has unfolded, thanks to the license deal with Sanofi (SNY). The deal signed with Sanofi on May 10, 2024, relates ...
KP.2 is now the dominant COVID variant. Experts say US may see a summer increase in cases
ABC News via Yahoo News· 2 hours agoFor the last few months, JN.1 has been the dominant COVID-19 variant in the United States, making up...
AstraZeneca pulls its COVID-19 vaccine from the European market
San Francisco Chronicle· 5 days agoThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine...
